1. The use of N-acetylated oligosaccharide, galactooligosaccharide and sialylated oligosaccharide to obtain a nutritional composition for administration to infants in the first six months of life to reduce the risk of obesity later in life. ! 2. The use of N-acetylated oligosaccharide, galactooligosaccharide and sialylated oligosaccharide to obtain a nutritional composition for administration to infants in the first six months of life to reduce lipogenesis in infants. ! 3. The use of N-acetylated oligosaccharide, galactooligosaccharide and sialylated oligosaccharide to obtain a nutritional composition for administration to infants in the first six months of life to reduce the stimulation of beta-oxidation of fatty acids in infants. ! 4. The use according to any one of claims 1 to 3, where the N-acetylated oligosaccharide is GalNAcα1,3Galβ1,4Glc, Galβ1,6GalNAcα1,3Galβ1,4Glc or a mixture thereof. ! 5. The use according to any one of claims 1 to 3, where the galactooligosaccharide is Galβ1,6Gal, Galβ1,6Galβ1,4Glc Galβ1,6Galβ1,6Glc, Galβ1,3Galβ1,3Glc, Galβl, 3Galβ1,4Glc, Galβ1,6Galβ1,6Galβ1,4Glc , Galβ1,6Galβ1,3Galβ1,4Glc Galβ1,3Galβ1,6Galβ1,4Glc, Galβ1,3Galβ1,3Galβ1,4Glc, Galβ1,4Galβ1,4Glc and Galβ1,4Galβ1,4Galβ1,4Glc or a mixture thereof. ! 6. The use according to any one of claims 1 to 3, wherein the sialylated oligosaccharide is NeuAcα2,3Galβ1,4Glc, NeuAcα2,6Galβ1,4Glc, or a mixture thereof. ! 7. Nutrient composition for administration to infants, which contains, based on dry matter, from 2.5 to 15.0 wt.% A mixture of oligosaccharides consisting of N-acetylated oligosaccharide (s), galactooligosaccharide (s) and sialylated oligosaccharide (s) , provided that the composition contains at least 0.02 wt.% N-acetylated oligosaccharide of at least 2.0 m�1. Применение N-ацетилированного олигосахарида, галактоолигосахарида и сиалилированного олигосахарида для получения питательной композиции для введения грудным детям в первые шесть месяцев жизни для снижения риска развития
